Home High-Flow Nasal Cannula in Patients with Chronic Respiratory Failure: A Literature Review and Suggestions for Clinical Practice
- PMID: 39965562
- PMCID: PMC12010723
- DOI: 10.4046/trd.2024.0196
Home High-Flow Nasal Cannula in Patients with Chronic Respiratory Failure: A Literature Review and Suggestions for Clinical Practice
Abstract
High-flow nasal cannula (HFNC) is a noninvasive respiratory support system that delivers air that is heated at 31°C-38°C, humidified 100%, and oxygen-enriched at a constant high flow rate of 15-60 L/min. Because of its numerous physiological benefits, convenience, and minimal side effects, HFNC has been increasingly used over the past decade in patients with acute hypoxemic respiratory failure, yet the clinical benefits of long-term HFNC remain uncertain. Several studies have suggested its potential use as an alternative home oxygen therapy for patients with chronic stable lung diseases, such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and bronchiectasis. The use of long-term home HFNC in patients with chronic respiratory failure is an emerging area with promising potential. Despite limited clinical research, this review aims to describe the physiology of HFNC use and summarize the current evidence on its long-term application, to provide healthcare providers with insights and perspectives on the potential role of long-term home HFNC.
Keywords: Chronic Lung Disease; High-Flow Nasal Cannula; Home; Oxygen.
Conflict of interest statement
Jae Hwa Cho is a deputy editor of the journal, but he was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.
Similar articles
-
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients.Rev Recent Clin Trials. 2019;14(4):247-260. doi: 10.2174/1574887114666190710180540. Rev Recent Clin Trials. 2019. PMID: 31291880
-
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure.Int J Chron Obstruct Pulmon Dis. 2018 Apr 16;13:1195-1205. doi: 10.2147/COPD.S159666. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29713153 Free PMC article. Clinical Trial.
-
High flow nasal cannula for adult acute hypoxemic respiratory failure in the ED setting.Am J Emerg Med. 2021 Nov;49:352-359. doi: 10.1016/j.ajem.2021.06.074. Epub 2021 Jul 3. Am J Emerg Med. 2021. PMID: 34246166 Free PMC article. Review.
-
High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.Crit Care. 2020 Aug 6;24(1):489. doi: 10.1186/s13054-020-03214-9. Crit Care. 2020. PMID: 32762701 Free PMC article. Clinical Trial.
-
The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: A systematic review and meta-analysis.Heart Lung. 2023 Jul-Aug;60:116-126. doi: 10.1016/j.hrtlng.2023.02.016. Epub 2023 Mar 23. Heart Lung. 2023. PMID: 36965283
References
-
- Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–96. - PubMed
-
- Jacome C, Jacome M, Correia S, Flores I, Farinha P, Duarte M, et al. Effectiveness, adherence and safety of home high flow nasal cannula in chronic respiratory disease and respiratory insufficiency: a systematic review. Arch Bronconeumol. 2024;60:490–502. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous